Andrea Cooper

Prof. Andrea Cooper

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2007 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SKShabaana A Khader
Shabaana A Khader
GBGuy K Bell
Guy K Bell
JPJohn E Pearl
John E Pearl
JFJeffrey J Fountain
Jeffrey J Fountain
RJRangel Moreno Javier
Rangel Moreno Javier
ACAndrea Cooper
Andrea Cooper

1 April 2009 in Annual Review of Immunology
Verified
Journal Article
Closed access
ACAndrea Cooper
Andrea Cooper
Tuberculosis is primarily a disease of the lung, and dissemination of the disease depends on productive infection of this critical organ. Upon aerosol infection with Mycobacterium tuberculosis (Mtb), the acquired cellular immune response is slow to be induced and to be expressed within the lung. This slowness allows infection to become well established; thus, the acquired response is expressed in an inflammatory site that has been initiated and modulated by the bacterium. Mtb has a variety of surface molecules that interact with the innate response, and this interaction along with the autoregulation of the immune response by several mechanisms results in less-than-optimal control of bacterial growth. To improve current vaccine strategies, we must understand the factors that mediate induction, expression, and regulation of the immune response in the lung. We must also determine how to induce both known and novel immunoprotective responses without inducing immunopathologic consequences.

29 June 2015 in Nature Medicine
Verified
Journal Article
Closed access
MTMichele W L Teng
Michele W L Teng
EBEdward P Bowman
Edward P Bowman
JMJoshua J McElwee
Joshua J McElwee
MSMark J Smyth
Mark J Smyth
JCJean-Laurent Casanova
Jean-Laurent Casanova
DCDaniel J Cua
Daniel J Cua

7 July 1997 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ACAndrea Cooper
Andrea Cooper
JMJeanne Magram
Jeanne Magram
JFJessica Ferrante
Jessica Ferrante
IOIan M. Orme
Ian M. Orme
Immunity to Mycobacterium tuberculosis infection is associated with the emergence of protective CD4 T cells that secrete cytokines, resulting in activation of macrophages and the recruitment of monocytes to initiate granuloma formation. The cytokine-mediating macrophage activation is interferon-γ (IFN-γ), which is largely dependent on interleukin-12 (IL-12) for its induction. To address the role of IL-12 in immunity to tuberculosis, IL-12 p40−/− mice were infected with M. tuberculosis and their capacity to control bacterial growth and other characteristics of their immune response were determined. The IL-12 p40−/− mice were unable to control bacterial growth and this appeared to be linked to the absence of both innate and acquired sources of IFN-γ. T cell activation as measured by delayed type hypersensitivity and lymphocyte accumulation at the site of infection were both markedly reduced in the IL-12 p40−/− mice. Therefore, IL-12 is essential to the generation of a protective immune response to M. tuberculosis, with its main functions being the induction of the expression of IFN-γ and the activation of antigen-specific lymphocytes capable of creating a protective granuloma.

7 August 2015 in Science
Verified
Journal Article
Closed access
PDF file
SOSatoshi Okada
Satoshi Okada
JMJanet G. Markle
Janet G. Markle
EDElissa K. Deenick
Elissa K. Deenick
FMFederico Mele
Federico Mele
DADina Averbuch
Dina Averbuch
JCJean-Laurent Casanova
Jean-Laurent Casanova
A surprising immune twist for RORC: The immune system needs its full array of soldiers—including cells and the molecules they secrete—to optimally protect the host. When this isn't the case, minor infections can become chronic or even deadly. Markle et al. report the discovery of seven individuals carrying loss-of-function mutations in RORC, which encodes the transcription factors RORγ and RORγT. These individuals lacked immune cells that produce the cytokine interleukin-17, causing them to suffer from chronic candidiasis. RORC-deficient individuals also exhibited impaired immunity to mycobacterium, probably due to reduced production of the cytokine interferon-γ, a molecule not known to require RORC for its induction. Science , this issue p. 606

15 July 2005 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SKShabaana A Khader
Shabaana A Khader
JPJohn E Pearl
John E Pearl
KSKaori Sakamoto
Kaori Sakamoto
LGLeigh Gilmartin
Leigh Gilmartin
GBGuy K. Bell
Guy K. Bell
ACAndrea Cooper
Andrea Cooper
IL-12p70 induced IFN-γ is required to control Mycobacterium tuberculosis growth; however, in the absence of IL-12p70, an IL-12p40-dependent pathway mediates induction of IFN-γ and initial bacteriostatic activity. IL-23 is an IL-12p40-dependent cytokine containing an IL-12p40 subunit covalently bound to a p19 subunit that is implicated in the induction of CD4 T cells associated with autoimmunity and inflammation. We show that in IL-23 p19-deficient mice, mycobacterial growth is controlled, and there is no diminution in either the number of IFN-γ-producing Ag-specific CD4 T cells or local IFN-γ mRNA expression. Conversely, there is an almost total loss of both IL-17-producing Ag-specific CD4 T cells and local production of IL-17 mRNA in these mice. The absence of IL-17 does not alter expression of the antimycobacterial genes, NO synthase 2 and LRG-47, and the absence of IL-23 or IL-17, both of which are implicated in mediating inflammation, fails to substantially affect the granulomatous response to M. tuberculosis infection of the lung. Despite this redundancy, IL-23 is required to provide a moderate level of protection in the absence of IL-12p70, and this protection correlates with a requirement for IL-23 in the IL-12p70-independent induction of Ag-specific, IFN-γ-producing CD4 T cells. We also show that IL-23 is required for the induction of an IL-17-producing Ag-specific phenotype in naive CD4 T cells in vitro and that absence of IL-12p70 promotes an increase in the number of IL-17-producing Ag-specific CD4 T cells both in vitro and in vivo.